2018 Webinar: Role of Diet and Exercise in the Management of NAFLD

5 (2 votes)

Recorded On: 04/24/2018

In this webinar, we will review the role of diet and exercise in the management of NAFLD. Specifically, we will overview the data in support of specific nutritional programs and physical activity regimens that have been shown to improve histologic components of NAFLD and NASH. Lastly, we will outline the remaining knowledge gaps and barriers related to lifestyle interventions in the treatment of NAFLD/NASH.

Michelle Long

Michelle Long, MD, MSc is a clinical investigator and hepatologist at the Boston University School of Medicine and Boston Medical Center. Dr. Long is the Director of the Boston Medical Center’s Nonalcoholic Fatty Liver Disease (NAFLD) Research Center and she is the Director of Clinical Research for the Section of Gastroenterology & Hepatology in the Department of Medicine. Dr. Long is primarily interested in patient-oriented research investigating fibrosis and inflammation in patients with NAFLD, including the overlap between NAFLD and cardiometabolic disease. Dr. Long is an investigator in the Framingham Heart Study where she is the Principal Investigator on a multi-year, multi-generational effort to evaluate the genetic and clinical correlates of liver fat and fibrosis as measured by transient elastography. She is the Principal Investigator for several ongoing Phase II and Phase III clinical trials in NAFLD. Dr. Long has received research funding from the National Institute of Health, Echosens Corporation, Gilead Sciences, The Doris Duke Research Foundation, and Boston University. She serves on the Liver-Biliary Council for the American Gastroenterological Association and on the Training and Workforce Committee for the American Association for the Study of Liver Diseases. Dr. Long is also an Associate Editor for Liver International.

Monica A. Konerman

Dr. Monica Konerman is a Clinical Lecturer in Internal Medicine in the Division of Gastroenterology and Hepatology at the University of Michigan. She is board certified in Transplant Hepatology and conducts clinical and health services research. Her areas of interest include NAFLD/NASH, liver transplant, and clinical risk prediction.

Rohit Loomba (Moderator)

Dr. Rohit Loomba is a Professor of Medicine (with tenure), Director of Hepatology, and Vice Chief, Division of Gastroenterology at University of California at San Diego. He is an internationally recognized thought leader in translational research and innovative clinical trial design in nonalcoholic fatty liver disease (NAFLD) and steatohepatitis (NASH), and non-invasive assessment of steatosis and fibrosis using advanced imaging modalities. Dr. Loomba is the founding director of the UCSD NAFLD Research Center where his team is conducting cutting edge research in all aspects of NAFLD including non-invasive biomarkers, genetics, epidemiology, clinical trial design, imaging end-points, and integrated OMICs using microbiome, metabolome and lipidome.

Components visible upon registration.